Skip to content
V-Biognostics
Toggle menu
  • About
  • Contact
  • Products
    • Osteocalcin (1-49) Human (Synthetic)
    • Antibiotics
      • Amphotericin B (Fungizone)
      • Bestatin (Ubenimex)
      • Bleomycin Sulfate
      • Brefeldin A
      • Daptomycin
      • G418, Sulfate
      • Mitomycin C
      • Thiostrepton
      • Valinomycin
    • Protease Inhibitors 1
      • AEBSF
      • Alafosfalin (Synthetic)
      • ALLN (Calpain Inh. I)
      • ALLM (Calpain Inh. II)
      • Amastatin, HCl
      • Antipain, 2HCl
      • Bestatin, HCl
      • Calpain Inh. III
      • Calpeptin
    • Protease Inhibitors 2
      • E-64 (Synthetic)
      • E-64d
      • Elastase Inh. I
      • Leupeptin, HCl
      • Leupeptin, Hemisulfate
      • MG-132
      • Pepstatin A
      • Phosphoramidon
      • RG108
      • TLCK, HCl
  • GERBU
    • GERBU Esterquat Product List
    • GERBU Adjuvant Product List
    • GERBU Adjuvant Introduction
    • GERBU Adjuvants Product Manuals
  • Articles
  • Email Logo

Category: News

September 18, 2018News

Medical Research from Mars Can Fail Patients from Venus

BIOtech Now Jim Greenwood Historically, federal dollars inadvertently flowed to medical research with a disproportionate focus on men’s health. There are several […]

September 14, 2018News

Pathbreaking Biotech Investor—Dr. Beth Seidenberg—to Speak at #BIF18

BIOtech Now Theresa Brady The rapid pace of scientific discovery, FDA approvals, commercialization of medicines held long in pipelines, and numerous IPOs […]

September 13, 2018News

Bloomberg Exposes How Drug Cost Middlemen “Rake in Millions”

BIOtech Now Andrew Segerman Bloomberg has authored an investigative piece exposing drug cost middlemen, better known as pharmacy benefit managers (PBMs), for […]

September 11, 2018News

Greenwood Highlights Role of Innovation in Solving Opioid Crisis

BIOtech Now Andrew Segerman The numbers are staggering. The opioid epidemic is costing our nation more than $500 billion annually in health and social […]

September 10, 2018News

The Patient Perspective-Valuable for Drug Development

BIOtech Now Theresa Brady Congress, the Food and Drug Administration (FDA), drug developers, researchers and patient groups have all recognized the contribution […]

September 6, 2018News

Healthcare AI is Booming

BIOtech Now Jeremy Isenberg Emerging technologies are disrupting the healthcare system as we know it—none more so than artificial intelligence (AI), which […]

August 30, 2018News

National Immunization Awareness Month is Timely Reminder of Modern Marvel of Vaccines

BIOtech Now Phyllis Arthur August marks National Immunization Awareness Month – a time to take inventory on where we stand, and recognize […]

August 28, 2018News

Vaccine Video Series Aims to Educate on the Benefits of Immunization

BIOtech Now Andrew Segerman National Immunization Awareness Month might be coming to a close, but it’s important to continue helping people understand […]

August 27, 2018News

Report: Patients More Likely to Skip Therapy as Out-of-Pocket Costs Rise

BIOtech Now Andrew Segerman IQVIA — a nonpartisan health care research firm — is out with troubling new data showing a direct […]

August 22, 2018News

PBS NewsHour: Why a Patient Paid a $285 Copay for a $40 Drug

BIOtech Now Andrew Segerman A featured story by PBS NewsHour reaffirms that insurance companies and drug cost middlemen determine what patients pay […]

August 21, 2018News

Senate Has the Power to Get Miracle Medications to Opioid Addicts

BIOtech Now Jim Greenwood BIO President and CEO Jim Greenwood posted the following op-ed on Linked-In today, making the case for the […]

August 17, 2018News

Changes to the Pandemic and All Hazards Preparedness Act are essential to saving lives in disasters

BIOtech Now Andrew Segerman Writing for The Hill, Dr. Robert Kadlec, Assistant Secretary for Preparedness and Response for the U.S. Department of […]

July 31, 2018News

Pfizer CEO: How the Biopharmaceutical Industry Creates Value (And Jobs) for the U.S. Economy

BIOtech Now Andrew Segerman In a recent piece for Forbes, Pfizer’s Chairman and CEO Ian Read highlights the significant economic value that […]

July 25, 2018News

As Out-of-Pocket Costs Rise, Insurers Spend Big on Administrative Costs

BIOtech Now Brian Newell It seems every week the insurance industry is busy pointing the finger at biopharmaceutical innovators for the rising […]

July 24, 2018News

Greenwood: America Leads in Biopharmaceutical Innovation. Let’s Keep It That Way.

BIOtech Now Andrew Segerman Writing last week for Morning Consult, BIO President and CEO Jim Greenwood proposed several policy ideas for Washington […]

July 19, 2018News

Insurers Should Prevent Pharmacy Counter Sticker Shock, Not Encourage It

BIOtech Now Trevor Roberts Sticker shock at the pharmacy counter is becoming increasingly more common for patients across the nation. But with […]

July 18, 2018News

Insurers and PBMs Limit Access to Safer Opioid Alternatives

BIOtech Now Andrew Segerman Opioid abuse and addiction in America continues to ravish communities, families, and individuals across the nation. With an […]

July 13, 2018News

Debunking a Common Myth on Out-of-Pocket Costs

BIOtech Now Jim Greenwood The facts continue to show that, when it comes to prescription drug costs, the country is heading in […]

July 11, 2018News

Four Questions for the Energy and Commerce Hearing on 340B

BIOtech Now Daniel Seaton Later this morning, the House Energy and Commerce Committee will hold a hearing to examine the rampant abuse […]

July 9, 2018News

FDA Protects Patients While Promoting Innovation

BIOtech Now Daniel Seaton Today, 83 percent of children with cancer survive, compared to just 58 percent in the mid-1970s. Hepatitis C, […]

Posts navigation

< 1 … 34 35 36 … 47 >
Partnering with:   Quartett GERBU Adjuvants

V-BIOGNOSTICS, "Ingredients For Life" is a BioTech company devoted to research in life science reagents worldwide. We source difficult to find biochemicals for the advancement in research of antibody production, Immunohistochemistry, drug development, molecular biology, cell biology, cancer research, Immunotherapy, Oncology, drug discovery, and agricultural biotechnology. We work hard for speedy processing and delivery of your products and at very competitive pricing offering you a high quality alternative to big pharma for your sourcing and manufacturing needs.

D&B VERIFIED Seal

We Supply the highest quality protease inhibitors, antibiotics, and Adjuvants including: Bestatin HCl, Leupeptin Hemisulfate / Hydrochloride, AEBSF, G418, Elastatinal, E-64, Pepstatin, Calpain, Bleomycin Sulfate, Proteinase K, MG-132, ALLM, ALLN, Antipain, Anti-Human Rabbit IgG, GERBU Monoclonal/Polyclonal Adjuvant, synthetic and custom synthesis. Please Contact Us or visit our Products, About, or Terms pages for more information.

Biotech Articles

  • How can proteomic analysis improve our understanding of the ageing process. Find out in your latest issue of BioTechniques!
  • Mutated gene is the driver of psoriasis
  • The latest developments in microbiology from a diverse cast of characters
  • Scientists stymie sarcopenia
  • Decoding the neuroanatomical signature of developmental language disorder
  • Lac-Phe: the mechanism behind metformin’s role in weight loss
© 2025 V-Biognostics. Proudly powered by Sydney